| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 231 |
| 1 | ADAPALENE | 91 |
| 2 | BIMATOPROST | 91 |
| 3 | CYCLOSPORINE | 30 |
| 4 | ETANERCEPT | 27 |
| 5 | BRIMONIDINE TARTRATE, TIMOLOL MALEATE | 24 |
| 6 | LEVOTHYROXINE SODIUM | 18 |
| 7 | SALICYLIC ACID | 18 |
| 8 | METHOTREXATE SODIUM | 17 |
| 9 | ADALIMUMAB | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE AND ACETIC ACID | 1 | 0.0233 |
| 1 | ALCAFTADINE | 8 | 0.0088 |
| 2 | MOISTURIZER | 1 | 0.0083 |
| 3 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 7 | 0.0062 |
| 4 | BRIMONIDINE TARTRATE, TIMOLOL MALEATE | 24 | 0.0036 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 8 | 0.0032 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 8 | 0.0032 |
| 7 | BIMATOPROST | 91 | 0.0031 |
| 8 | LOTILANER OPHTHALMIC SOLUTION | 11 | 0.0028 |
| 9 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 2 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 231 |
| 1 | Prostaglandin Analog [EPC] | 112 |
| 2 | Retinoid [EPC] | 95 |
| 3 | Corticosteroid [EPC] | 38 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 33 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 30 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 7 | Vitamin C [EPC] | 15 |
| 8 | Aminosalicylate [EPC] | 14 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ectoparasiticide [EPC] | 11 | 0.0028 |
| 1 | Prostaglandin Analog [EPC] | 112 | 0.0012 |
| 2 | Interleukin-13 Antagonist [EPC] | 8 | 0.0012 |
| 3 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 4 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 14 | 0.0008 |
| 5 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 231 | 0.0004 |
| 7 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 8 | Retinoid [EPC] | 95 | 0.0004 |
| 9 | Plasma Volume Expander [EPC] | 1 | 0.0003 |